CN114680336A - Drop containing fructus cannabis unsaturated fatty acid and preparation method thereof - Google Patents
Drop containing fructus cannabis unsaturated fatty acid and preparation method thereof Download PDFInfo
- Publication number
- CN114680336A CN114680336A CN202011607775.7A CN202011607775A CN114680336A CN 114680336 A CN114680336 A CN 114680336A CN 202011607775 A CN202011607775 A CN 202011607775A CN 114680336 A CN114680336 A CN 114680336A
- Authority
- CN
- China
- Prior art keywords
- unsaturated fatty
- fatty acid
- fructus cannabis
- oil
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B20/00—Preservation of edible oils or fats
- A23B20/30—Preservation of other edible oils or fats, e.g. shortenings or cooking oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
- A23D9/013—Other fatty acid esters, e.g. phosphatides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
技术领域technical field
本发明涉及食品领域,具体涉及一种含火麻仁不饱和脂肪酸的滴剂及其制备方法。The invention relates to the field of food, in particular to a hemp seed unsaturated fatty acid-containing drop and a preparation method thereof.
背景技术Background technique
随着社会进步和人们生活水平的提高以及医疗保障的改善,目前我国人口的平均寿命显著提高,同时老年人占总人口的比例不断上升。庞大的老年人口需要大家切实关注老年人身体健康问题,提高老年人自我保健和预防疾病的能力。科学研究发现60岁以后大脑细胞衰老速度开始加快,记忆力下降及阿尔茨海默病(老年痴呆)发生率升高。老年痴呆患者的症状表现为认知功能损害和精神异常,最终生活无法自理,这不仅会严重影响患者的生活质量,也给患者家庭和社会带来沉重的负担。至今为止老年痴呆症是无法治愈的,目前市面上的常规药物只能缓解老年痴呆症状,药效很短,不能控制病情的发展。现在还没有药物能永久停止患者的脑萎缩,因此开发一种能减缓老年人记忆力减退,提高老年人记忆力,预防老年痴呆的食品具有十分重要的意义。With the progress of society, the improvement of people's living standards and the improvement of medical security, the average life expectancy of my country's population has increased significantly, and the proportion of the elderly in the total population has continued to rise. The huge elderly population requires everyone to pay attention to the physical health of the elderly and improve the ability of the elderly to self-care and prevent diseases. Scientific research has found that the aging speed of brain cells begins to accelerate after the age of 60, the memory decline and the incidence of Alzheimer's disease (senile dementia) increase. The symptoms of Alzheimer's patients are manifested as cognitive impairment and mental disorders, and eventually they cannot take care of themselves, which will not only seriously affect the quality of life of the patients, but also bring a heavy burden to the patient's family and society. So far, Alzheimer's disease is incurable. The conventional drugs currently on the market can only relieve the symptoms of Alzheimer's disease, and the efficacy of the drugs is very short, which cannot control the development of the disease. There is no drug that can permanently stop the brain atrophy of patients. Therefore, it is of great significance to develop a food that can slow down the memory loss of the elderly, improve the memory of the elderly, and prevent Alzheimer's disease.
火麻仁是一种非常好的油加工原料以及食品原料。火麻仁中的Omega-3不饱和脂肪酸是一组多元不饱和脂肪酸,有助于健脑益智,保持血管畅通,预防血栓或血脂等心脑血管等疾病的发生,其中的α-亚麻酸在人体内可以转化成维持脑神经运作的二十二碳六烯酸(DHA),提供给大脑充足的营养。人体内缺乏α-亚麻酸容易导致Omega-3不饱和脂肪酸摄入不足从而引起脑萎缩,对老年人来说,缺乏α-亚麻酸会增加老年痴呆的发生几率。Hemp seed is a very good raw material for oil processing and food. Omega-3 unsaturated fatty acids in hemp seeds are a group of polyunsaturated fatty acids, which help to strengthen the brain, keep blood vessels open, and prevent the occurrence of cardiovascular and cerebrovascular diseases such as thrombosis or blood lipids. Among them, α-linolenic acid In the human body, it can be converted into docosahexaenoic acid (DHA), which maintains the operation of brain nerves, and provides sufficient nutrients to the brain. Lack of alpha-linolenic acid in the human body can easily lead to insufficient intake of Omega-3 unsaturated fatty acids and cause brain atrophy. For the elderly, lack of alpha-linolenic acid will increase the risk of Alzheimer's.
服用Omega-3能够增强学习能力、记忆力和专注力。由于Omega-3不饱和脂肪酸在体内不能自我合成,所以Omega-3不饱和脂肪酸只能从食物中摄取,而日常食品中所含少量的Omega-3不饱和脂肪酸不能满足人体的需要,故需要通过外部摄取补充这类必需的不饱和脂肪酸来改善人体的健康状况。Taking Omega-3 can enhance learning ability, memory and concentration. Since Omega-3 unsaturated fatty acids cannot be synthesized by themselves in the body, Omega-3 unsaturated fatty acids can only be taken in from food, and a small amount of Omega-3 unsaturated fatty acids contained in daily food cannot meet the needs of the human body, so it is necessary to pass External supplementation of these essential unsaturated fatty acids improves human health.
目前,市售的富含Omega-3不饱和脂肪酸的产品主要以胶囊的形式出现,如DHA软胶囊、鱼油软胶囊、磷虾油胶囊等,然而现有产品储存期均不长,且胶囊中的油包载量并不多,富含Omega-3不饱和脂肪酸的油溶解性较差,不利于人体吸收,其生物利用度并不高,影响产品发挥功效。At present, commercially available products rich in Omega-3 unsaturated fatty acids are mainly in the form of capsules, such as DHA soft capsules, fish oil soft capsules, krill oil capsules, etc. However, the storage period of the existing products is not long, and the capsules Omega-3 unsaturated fatty acid-rich oil has poor solubility, which is not conducive to human absorption, and its bioavailability is not high, which affects the efficacy of the product.
因此,需要开发一种储存期长、生物利用度高的不饱和脂肪酸产品。Therefore, there is a need to develop an unsaturated fatty acid product with a long shelf life and high bioavailability.
发明内容SUMMARY OF THE INVENTION
针对现有技术的不足,本发明的一个目的在于提供一种含火麻仁不饱和脂肪酸的滴剂,该滴剂各营养成分配比合理,体内生物利用率高,且质量稳定、储存期长,具有辅助增强记忆力、预防老年痴呆、降血脂等多种作用;本发明的又一个目的在于提供该滴剂的制备方法,该制备方法具有操作简单、适合大规模化生产的优点。Aiming at the deficiencies of the prior art, an object of the present invention is to provide a kind of drops containing hemp seed unsaturated fatty acid, the ratio of each nutritional component of the drops is reasonable, the bioavailability in vivo is high, and the quality is stable and the storage period is long. , has multiple functions such as assisting memory enhancement, preventing senile dementia, lowering blood lipids, etc. Another object of the present invention is to provide a preparation method of the drops, which has the advantages of simple operation and suitable for large-scale production.
一方面,本发明提供了含火麻仁不饱和脂肪酸的滴剂,包含如下质量百分数的组分:On the one hand, the present invention provides the hemp seed unsaturated fatty acid-containing drops, comprising the following components by mass percentage:
DHA藻油:5-25%;DHA algal oil: 5-25%;
火麻仁不饱和脂肪酸:5-65%;Hemp seed unsaturated fatty acids: 5-65%;
大豆磷脂:3-15%;Soy lecithin: 3-15%;
矫味剂:0.1-0.8%;Flavoring agent: 0.1-0.8%;
火麻仁油:余量。Hemp seed oil: balance.
在优选的实施方案中,本发明的含火麻仁不饱和脂肪酸的滴剂包含如下质量百分数的组分:In a preferred embodiment, the hemp seed unsaturated fatty acid-containing drops of the present invention comprise the following components in mass percentage:
DHA藻油:10-20%;DHA algal oil: 10-20%;
火麻仁不饱和脂肪酸:10-60%;Hemp seed unsaturated fatty acids: 10-60%;
大豆磷脂:5-10%;Soy lecithin: 5-10%;
矫味剂:0.3-0.5%;Flavoring agent: 0.3-0.5%;
火麻仁油:余量。Hemp seed oil: balance.
DHA藻油是海藻中全部油类物质的总称,常温下多为略带腥味的淡黄色液体,主要有效成分有EPA和DHA等,研究表明DHA藻油具有降血脂,降血压,降胆固醇,改善血栓,预防心血管疾病的作用。DHA是大脑细胞形成发育及运动不可缺少的物质基础。DHA在体内水平的高低会直接影响脑细胞的增值、神经传导、突触的生长和发育。人的记忆力、思维功能都有赖于DHA来维持和提高。补充DHA可促进脑细胞充分发育,延缓智力下降、健忘及预防阿尔茨海默病等。DHA algae oil is the general term for all the oily substances in seaweed. It is mostly a light yellow liquid with a slightly fishy smell at room temperature. The main active ingredients are EPA and DHA, etc. Improve blood clots and prevent cardiovascular disease. DHA is an indispensable material basis for the formation, development and movement of brain cells. The level of DHA in the body directly affects the proliferation of brain cells, nerve conduction, and the growth and development of synapses. Human memory and thinking function depend on DHA to maintain and improve. DHA supplementation can promote the full development of brain cells, delay mental decline, forgetfulness and prevent Alzheimer's disease.
火麻仁不饱和脂肪酸为高级保健食用油,不饱和脂肪酸含量≥92%,亚油酸ω-6≥56%,亚麻酸ω-3≥14%,富含天然VA、VD等营养物质。火麻仁不饱和脂肪酸有健脑养脑的作用,火麻仁不饱和脂肪酸中不含胆固醇,可有效预防老年痴呆症的发生,丰富的亚油酸和亚麻酸能排除血管内新陈代谢的杂质,使血液净化,为大脑提供新鲜血液。α-亚麻酸是有三个双键的多元不饱和脂肪酸,是一种ω-3必需脂肪酸,用于提高智力作用,抗血栓、保肝等,是人们必须的营养素之一。Hemp seed unsaturated fatty acids are high-grade health-care edible oils, with unsaturated fatty acid content ≥92%, linoleic acid ω-6 ≥56%, linolenic acid ω-3 ≥14%, rich in natural VA, VD and other nutrients. Hemp seed unsaturated fatty acids have the effect of strengthening the brain and nourishing the brain. Hemp seed unsaturated fatty acids do not contain cholesterol, which can effectively prevent the occurrence of Alzheimer's disease. It purifies the blood and supplies fresh blood to the brain. Alpha-linolenic acid is a polyunsaturated fatty acid with three double bonds. It is an omega-3 essential fatty acid. It is used to improve intelligence, antithrombosis, and liver protection. It is one of the essential nutrients for people.
大豆磷脂从生理活性看,大豆磷脂是通过酯交换反应将中碳链油脂、共轭亚油酸、植物淄醇或n-3系列多不饱和脂肪酸等不饱和脂肪酸引入磷脂分子中而获得,大豆磷脂不仅保持了磷脂良好的乳化特性,而且还使磷脂的营养价值得到大幅的改善,与DHA藻油、火麻仁不饱和脂肪酸配合使用具有较好的促进吸收效果。大豆磷脂类似于血脑屏障的钥匙或载体,运载着DHA藻油中DHA和火麻仁不饱和脂肪酸中亚麻酸ω-3等营养成分通过血脑屏障进入脑部,给人体脑部补充营养,提高记忆力,预防老年痴呆。From the perspective of physiological activity, soybean phospholipid is obtained by introducing unsaturated fatty acids such as medium carbon chain oil, conjugated linoleic acid, phytosterol or n-3 series polyunsaturated fatty acids into phospholipid molecules through transesterification reaction. Phospholipids not only maintain the good emulsifying properties of phospholipids, but also greatly improve the nutritional value of phospholipids. When used together with DHA algal oil and hemp seed unsaturated fatty acids, they have a better effect of promoting absorption. Soybean phospholipids are similar to the key or carrier of the blood-brain barrier, carrying nutrients such as DHA in DHA algal oil and linolenic acid omega-3 in unsaturated fatty acids of hemp seeds into the brain through the blood-brain barrier, supplementing nutrition to the human brain, Improve memory and prevent Alzheimer's.
本发明的含火麻仁不饱和脂肪酸的滴剂中各营养物质之间配比合理,符合国际要求,本发明滴剂中,各成分组合后营养成分的吸收率、利用率高,尤其可以显著提升DHA的体内生物利用率。上述各营养成分合理搭配,具有辅助改善记忆力,预防老年痴呆、降血脂等多种作用。In the hemp seed unsaturated fatty acid-containing drops of the present invention, the proportions of nutrients are reasonable and meet international requirements. Improve the bioavailability of DHA in vivo. The reasonable combination of the above nutrients can help improve memory, prevent senile dementia, and lower blood lipids.
在优选的实施方案中,在所述含火麻仁不饱和脂肪酸的滴剂中,所述矫味剂是由乙基麦芽酚和食品香精组成的混合物,其中乙基麦芽酚和食品香精的质量比为2:3。In a preferred embodiment, in the hemp seed unsaturated fatty acid-containing drops, the flavoring agent is a mixture of ethyl maltol and food flavor, wherein the quality of ethyl maltol and food flavor The ratio is 2:3.
本发明的含火麻仁不饱和脂肪酸的滴剂中的乙基麦芽酚和食品香精扩散到口中,从而完全遮盖住滴剂中原料组分的不良气味,使得滴剂更易食用。The ethyl maltol and food essence in the hemp seed unsaturated fatty acid-containing drops of the present invention diffuse into the mouth, thereby completely covering the bad smell of the raw material components in the drops, making the drops easier to eat.
在优选的实施方案中,所述含火麻仁不饱和脂肪酸的滴剂还包含0.1%-1.5%质量百分数的抗氧化剂,优选0.5%-1%质量百分数的抗氧化剂。In a preferred embodiment, the hemp seed unsaturated fatty acid-containing drops further comprise 0.1%-1.5% by mass of antioxidants, preferably 0.5%-1% by mass of antioxidants.
在优选的实施方案中,在所述含火麻仁不饱和脂肪酸的滴剂中,抗氧化剂可以是维生素C、维生素E或其组合。In a preferred embodiment, in the hemp seed unsaturated fatty acid-containing drops, the antioxidant may be vitamin C, vitamin E, or a combination thereof.
在优选的实施方案中,本发明的含火麻仁不饱和脂肪酸的滴剂的粒径为350-500nm,优选400-450nm。In a preferred embodiment, the particle size of the hemp seed unsaturated fatty acid-containing drops of the present invention is 350-500 nm, preferably 400-450 nm.
本发明的滴剂是一种液体制剂,为多相相互分散形成的非均相液体分散体系,本发明的滴剂的粒径在350-500nm,优选400-450nm之间,使得滴剂更加稳定,保质期较长。The drop of the present invention is a liquid preparation, which is a heterogeneous liquid dispersion system formed by multiphase mutual dispersion. The particle size of the drop of the present invention is 350-500 nm, preferably 400-450 nm, so that the drop is more stable , the shelf life is longer.
又一方面,本发明提供了含火麻仁不饱和脂肪酸的滴剂的制备方法,包括以下步骤:On the other hand, the invention provides the preparation method of the drop containing hemp seed unsaturated fatty acid, comprises the following steps:
1)DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂、矫味剂和火麻仁油混合均匀,制成混合液;1) DHA algal oil, hemp seed unsaturated fatty acid, soybean lecithin, flavoring agent and hemp seed oil are mixed evenly to make a mixed solution;
2)向制备好的混合液中,通入氮气保护,于20℃下,出料;2) Into the prepared mixed solution, nitrogen protection was introduced, and the material was discharged at 20°C;
3)灭菌、真空消泡、灌装,得到含火麻仁不饱和脂肪酸的滴剂。3) Sterilization, vacuum defoaming and filling to obtain hemp seed unsaturated fatty acid-containing drops.
在优选的实施方案中,在本发明的含火麻仁不饱和脂肪酸的滴剂的制备方法中,步骤2)中还加入抗氧化剂,其中抗氧化剂可以是维生素C、维生素E或其组合。In a preferred embodiment, in the preparation method of the hemp seed unsaturated fatty acid-containing drops of the present invention, an antioxidant is also added in step 2), wherein the antioxidant can be vitamin C, vitamin E or a combination thereof.
本发明采用分步混合的方式,将各原料按顺序并逐步加入到混合体系中,使其充分分散,得到的滴剂分散稳定,充氮气保护使稳定性提高,储存期延长。The method adopts the method of step-by-step mixing, and the raw materials are sequentially and gradually added into the mixing system to make it fully dispersed, and the obtained drops have stable dispersion, and nitrogen filling protection improves the stability and prolongs the storage period.
综上所述,与现有技术相比,本发明的含火麻仁不饱和脂肪酸的滴剂以及滴剂的制备方法具有以下有益效果:To sum up, compared with the prior art, the hemp seed unsaturated fatty acid-containing drops of the present invention and the preparation method of the drops have the following beneficial effects:
(1)本发明的含火麻仁不饱和脂肪酸的滴剂通过DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂、火麻油合理比例组合后,营养成分配比合理,营养成分生物利用率高,尤其可以显著提高DHA的体内生物利用率,具有辅助增强记忆力、预防老年痴呆、降血脂等多种作用;该滴剂采用充氮气保护的方式,且本发明的滴剂的粒径在350-500nm,优选400-450nm之间,使得滴剂更加稳定,保质期较长,可延长到2年,因此本发明的含火麻仁不饱和脂肪酸的滴剂具有储存期长的优点。(1) the drops of the present invention containing hemp seed unsaturated fatty acid are combined by DHA algae oil, hemp seed unsaturated fatty acid, soybean lecithin, hemp oil in reasonable proportion, the nutrient distribution ratio is reasonable, and the nutrient bioavailability is high , especially can significantly improve the in vivo bioavailability of DHA, and has multiple effects such as assisting memory enhancement, preventing senile dementia, and lowering blood lipids; the drops are protected by nitrogen gas, and the particle diameter of the drops of the present invention is 350- 500nm, preferably between 400-450nm, makes the drops more stable and has a longer shelf life, which can be extended to 2 years. Therefore, the hemp seed unsaturated fatty acid-containing drops of the present invention have the advantage of long storage period.
(2)本发明的滴剂的制备方法具有操作简单、适合大规模化生产的优点。(2) The preparation method of the drops of the present invention has the advantages of simple operation and suitable for large-scale production.
具体实施方式Detailed ways
为了更好地理解本发明的内容,下面结合实施例进一步进行阐述,但本发明的内容并不仅仅局限于这些实施例。In order to better understand the content of the present invention, the following is further described in conjunction with the embodiments, but the content of the present invention is not limited to these embodiments.
在下文中,如果未特别说明,本发明实施例中所使用的试剂均为本领域的常规试剂。矫味剂为乙基麦芽酚和食品香精按照质量比为2:3组成的混合物。所选DHA藻油为DHA含量75%的原料,火麻仁不饱和脂肪酸为α-亚麻酸含量55%的原料。Hereinafter, unless otherwise specified, the reagents used in the examples of the present invention are conventional reagents in the art. The flavoring agent is a mixture of ethyl maltol and food essence in a mass ratio of 2:3. The selected DHA algal oil is the raw material with a DHA content of 75%, and the unsaturated fatty acid of hemp seed is a raw material with a α-linolenic acid content of 55%.
实施例1:含火麻仁不饱和脂肪酸的滴剂的制备Embodiment 1: the preparation of the drops containing hemp seed unsaturated fatty acid
各组分及其相应的质量百分数如表1所示,并通过如下步骤制备获得:The components and their corresponding mass percentages are shown in Table 1, and are prepared by the following steps:
1)DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂、矫味剂和火麻仁油混合均匀,制成混合液;1) DHA algal oil, hemp seed unsaturated fatty acid, soybean lecithin, flavoring agent and hemp seed oil are mixed evenly to make a mixed solution;
2)向制备好的混合液中,通入氮气保护,于20℃下,出料;2) Into the prepared mixed solution, nitrogen protection was introduced, and the material was discharged at 20°C;
3)灭菌、真空消泡、灌装,得到含火麻仁不饱和脂肪酸的滴剂。3) Sterilization, vacuum defoaming and filling to obtain hemp seed unsaturated fatty acid-containing drops.
实施例2至实施例6:含火麻仁不饱和脂肪酸的滴剂的制备Example 2 to Example 6: Preparation of hemp seed unsaturated fatty acid-containing drops
以与实施例1相同的步骤,按照表1中实施例2至实施例6中各组分的质量百分数制备含火麻仁不饱和脂肪酸的滴剂。With the same steps as in Example 1, according to the mass percentage of each component in Example 2 to Example 6 in Table 1, the hemp seed unsaturated fatty acid-containing drops were prepared.
表1实施例1至实施例6中各组分及其质量百分数(总质量100g)Table 1 Each component and its mass percentage in Examples 1 to 6 (total mass 100g)
实施例7:含火麻仁不饱和脂肪酸的滴剂的制备Embodiment 7: the preparation of the drops containing hemp seed unsaturated fatty acid
各组分及其含量与实施例1相同,不同之处在于,通过如下步骤制备获得:The components and their contents are the same as in Example 1, except that they are prepared through the following steps:
1)DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂、矫味剂和火麻仁油混合均匀,制成混合液;1) DHA algal oil, hemp seed unsaturated fatty acid, soybean lecithin, flavoring agent and hemp seed oil are mixed evenly to make a mixed solution;
2)将制备好的混合液于20℃下,出料;2) Discharge the prepared mixed solution at 20°C;
3)灭菌、灌装,得到含火麻仁不饱和脂肪酸的滴剂。3) Sterilization and filling to obtain hemp seed unsaturated fatty acid-containing drops.
实施例8:含火麻仁不饱和脂肪酸的滴剂的制备Embodiment 8: the preparation of the drops containing hemp seed unsaturated fatty acid
DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂与矫味剂的质量百分含量与实施例1相同,与实施例1不同之处在于还含有0.1%质量百分数的抗氧化剂维生素C,余量为火麻仁油。制备方法如下:The mass percentages of DHA algae oil, hemp seed unsaturated fatty acids, soybean lecithin and the flavoring agent are the same as in Example 1, and the difference from Example 1 is that it also contains 0.1% by mass of antioxidant vitamin C, and the remainder For hemp seed oil. The preparation method is as follows:
1)DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂、矫味剂和火麻仁油混合均匀,制成混合液;1) DHA algal oil, hemp seed unsaturated fatty acid, soybean lecithin, flavoring agent and hemp seed oil are mixed evenly to make a mixed solution;
2)向制备好的混合液中,加入抗氧化剂,混匀,通入氮气保护,于20℃下,出料;2) To the prepared mixed solution, add antioxidant, mix well, introduce nitrogen protection, and discharge at 20°C;
3)灭菌、真空消泡、灌装,得到含火麻仁不饱和脂肪酸的滴剂。3) Sterilization, vacuum defoaming and filling to obtain hemp seed unsaturated fatty acid-containing drops.
实施例9:含火麻仁不饱和脂肪酸的滴剂的制备Embodiment 9: the preparation of the drops containing hemp seed unsaturated fatty acid
DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂与矫味剂的质量百分含量与实施例1相同,与实施例1不同之处在于还含有1%质量百分数的抗氧化剂维生素E,余量为火麻仁油。制备方法同实施例8。The mass percentages of DHA algal oil, hemp seed unsaturated fatty acids, soybean lecithin and the flavoring agent are the same as in Example 1, and the difference from Example 1 is that it also contains 1% by mass of antioxidant vitamin E, and the remainder For hemp seed oil. The preparation method is the same as in Example 8.
实施例10:含火麻仁不饱和脂肪酸的滴剂的制备Embodiment 10: the preparation of the drops containing hemp seed unsaturated fatty acid
DHA藻油、火麻仁不饱和脂肪酸、大豆磷脂与矫味剂的质量百分含量与实施例1相同,与实施例1不同之处在于还含有0.5%质量百分数的抗氧化剂,抗氧化剂为维生素C和维生素E按照质量比1:1组成的混合物,余量为火麻仁油。制备方法同实施例8。The mass percentages of DHA algae oil, hemp seed unsaturated fatty acids, soybean lecithin and flavoring agent are the same as in Example 1, and the difference from Example 1 is that it also contains 0.5% mass percentage of antioxidants, which are vitamins A mixture of C and vitamin E in a mass ratio of 1:1, and the balance is hemp seed oil. The preparation method is the same as in Example 8.
以下对比例1至对比例3中,替代组分的含量与实施例1中被替代的组分的含量相同,其他组分及其含量与实施例1相同。In the following Comparative Examples 1 to 3, the content of the replacement component is the same as that of the replaced component in Example 1, and the other components and their contents are the same as those of Example 1.
对比例1:口服滴剂的制备Comparative Example 1: Preparation of Oral Drops
按照与实施例1相同的步骤进行制备,与实施例1的不同之处在于,采用单甘脂替代实施例1中的大豆磷脂。The preparation was carried out according to the same steps as in Example 1, except that the soybean lecithin in Example 1 was replaced by monoglyceride.
对比例2:口服滴剂的制备Comparative Example 2: Preparation of Oral Drops
按照与实施例1相同的步骤进行制备,与实施例1的不同之处在于,采用橄榄油替代实施例1中的火麻仁油。Prepare according to the same steps as Example 1, and the difference from Example 1 is that olive oil is used to replace the hemp seed oil in Example 1.
对比例3:口服滴剂的制备Comparative Example 3: Preparation of Oral Drops
按照与实施例1相同的步骤进行制备,与实施例1的不同之处在于,采用橄榄油代替实施例1中的火麻仁不饱和脂肪酸。Prepare according to the same steps as Example 1, and the difference from Example 1 is that olive oil is used to replace the unsaturated fatty acid of hemp seed in Example 1.
对比例4:口服滴剂的制备Comparative Example 4: Preparation of Oral Drops
按照与实施例1相同的步骤进行制备,与实施例1的不同之处在于,采用火麻仁不饱和脂肪酸添加量为70%,DHA藻油、大豆磷脂、矫味剂的添加量同实施例1,用火麻仁油补齐余量。Prepare according to the same steps as Example 1, and the difference from Example 1 is that the addition of hemp seed unsaturated fatty acid is 70%, and the additions of DHA algal oil, soybean lecithin, and flavoring agent are the same as in Example 1. Make up the remaining amount with hemp seed oil.
对比例5:口服滴剂的制备Comparative Example 5: Preparation of Oral Drops
按照与实施例1相同的步骤进行制备,与实施例1的不同之处在于,采用DHA藻油添加量为30%,火麻仁不饱和脂肪酸、大豆磷脂、矫味剂的添加量同实施例1,用火麻仁油补齐余量。Prepare according to the same steps as Example 1. The difference from Example 1 is that the addition of DHA algae oil is 30%, and the additions of hemp seed unsaturated fatty acid, soybean lecithin, and flavoring agent are the same as those in Example 1. 1. Make up the remaining amount with hemp seed oil.
实验例Experimental example
生物利用度测试:Bioavailability Test:
选取雄性Wistar大鼠(北京大学医学部实验动物中心提供),体重260-280g,共160只,平均分为16组,实验前禁食12h,不禁火麻仁油。给大鼠分别灌胃实施例1-10和对比例1-6中的滴剂,在给药0.25h,0.5h,1h,2h,4h,6h,8h,12h和24h后,眼眶静脉丛采血0.5mL,收集于肝素化试管中,37℃火麻仁油浴保温30min后,5000r/min下低温离心10min,分离血浆取上清液,于-20℃保存待测定其药物浓度。DHA血液浓度-时间曲线测定数据经过DAS药动学计算后计入下表2中。A total of 160 male Wistar rats (provided by the Laboratory Animal Center, Department of Medicine, Peking University), weighing 260-280 g, were selected and divided into 16 groups. The drops in Examples 1-10 and Comparative Examples 1-6 were gavaged respectively in rats, and blood was collected from the orbital venous plexus after administration for 0.25h, 0.5h, 1h, 2h, 4h, 6h, 8h, 12h and 24h 0.5mL was collected in a heparinized test tube, incubated at 37°C in a hemp seed oil bath for 30min, centrifuged at a low temperature of 5000r/min for 10min, and the plasma was separated to take the supernatant, which was stored at -20°C until its drug concentration was determined. The measured data of DHA blood concentration-time curve are included in Table 2 below after DAS pharmacokinetic calculation.
表2 DHA生物利用度测试结果Table 2 DHA bioavailability test results
由表2中测试数据可以看出,滴剂中各组分之间相互影响,组分的替换以及组分配比的变化均对各组分的吸收产生影响。本申请保护的具有特定配比组分的滴剂使DHA生物利用度提高。具体地,实施例1-10中大鼠对滴剂的DHA生物利用度明显要高于对比例1-5中大鼠对滴剂的DHA生物利用度,尤其实施例9-10为最优实施例,其DHA生物利用度最高。It can be seen from the test data in Table 2 that the components in the drops interact with each other, and the replacement of components and the change of component distribution ratios all have an impact on the absorption of each component. The drops with specific proportioning components protected by the present application can improve the bioavailability of DHA. Specifically, the bioavailability of DHA to the drops in rats in Examples 1-10 is significantly higher than the bioavailability of DHA for the drops in rats in Comparative Examples 1-5, especially Examples 9-10 are the best implementations For example, its DHA bioavailability is the highest.
以上所述仅是本发明的优选实施方式,本发明的保护范围并不仅局限于上述实施例,凡属于本发明思路下的技术方案均属于本发明的保护范围。应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理前提下的若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above are only the preferred embodiments of the present invention, and the protection scope of the present invention is not limited to the above-mentioned embodiments, and all technical solutions under the idea of the present invention belong to the protection scope of the present invention. It should be pointed out that for those skilled in the art, some improvements and modifications without departing from the principle of the present invention should also be regarded as the protection scope of the present invention.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011607775.7A CN114680336A (en) | 2020-12-30 | 2020-12-30 | Drop containing fructus cannabis unsaturated fatty acid and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011607775.7A CN114680336A (en) | 2020-12-30 | 2020-12-30 | Drop containing fructus cannabis unsaturated fatty acid and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114680336A true CN114680336A (en) | 2022-07-01 |
Family
ID=82132809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011607775.7A Pending CN114680336A (en) | 2020-12-30 | 2020-12-30 | Drop containing fructus cannabis unsaturated fatty acid and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114680336A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679593A (en) * | 2005-02-04 | 2005-10-12 | 海南国栋药物研究所有限公司 | Composite preparation containing alpha-linolenic acid free acid, soybean phospholipid and vitamin E |
US20070032548A1 (en) * | 2005-07-08 | 2007-02-08 | Ellis Lorie A | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
CN105343184A (en) * | 2015-12-01 | 2016-02-24 | 无限极(中国)有限公司 | Composition and application thereof |
CN106729280A (en) * | 2016-12-27 | 2017-05-31 | 南京圣诺生物科技实业有限公司 | A kind of composition containing phosphatidylserine and its preparation method and application |
CN111743996A (en) * | 2020-06-24 | 2020-10-09 | 上海互众药业有限公司 | Oral emulsion for improving memory and senile dementia and preparation method thereof |
-
2020
- 2020-12-30 CN CN202011607775.7A patent/CN114680336A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1679593A (en) * | 2005-02-04 | 2005-10-12 | 海南国栋药物研究所有限公司 | Composite preparation containing alpha-linolenic acid free acid, soybean phospholipid and vitamin E |
US20070032548A1 (en) * | 2005-07-08 | 2007-02-08 | Ellis Lorie A | Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
CN105343184A (en) * | 2015-12-01 | 2016-02-24 | 无限极(中国)有限公司 | Composition and application thereof |
CN106729280A (en) * | 2016-12-27 | 2017-05-31 | 南京圣诺生物科技实业有限公司 | A kind of composition containing phosphatidylserine and its preparation method and application |
CN111743996A (en) * | 2020-06-24 | 2020-10-09 | 上海互众药业有限公司 | Oral emulsion for improving memory and senile dementia and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
萧闵 等: "火麻仁油与藻油混合物对营养肥胖大鼠的降脂减肥作用研究", 《湖北中医药大学学报》, vol. 18, no. 4, pages 12 - 15 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2093996C1 (en) | Method of addition to child's nutrient mixture of docosahexanoic and arachidonic acids (versions) and composition (versions) | |
US20020025983A1 (en) | Vitamin K and essential fatty acids | |
CN108402188A (en) | A kind of edible oil and preparation method for strengthening supplement DHA and alpha-linolenic acid | |
CN103891924A (en) | Blending oil containing corn oil and preparation method of blending oil | |
CN1891215A (en) | Compositions having an activity of ameliorating a reduced higher brain function resulting from organic brain lesions | |
KR20060127865A (en) | Fat and oil composition | |
CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
CN103190619A (en) | Fish oil and linseed oil soft capsules and preparation method thereof | |
CN105707292A (en) | Camellia blend oil suitable for infants | |
CN102578307A (en) | Dual-sub-acid high-end vegetable oil and preparation method thereof | |
CN105434331B (en) | A kind of self-emulsifying Co-Q10 finish and its preparation method and application | |
CN111743996A (en) | Oral emulsion for improving memory and senile dementia and preparation method thereof | |
CN105283190A (en) | A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease | |
CN105432792A (en) | Basic nutrition milk powder for preschool children, nutrition milk powder suit and preparation methods | |
CN101167793A (en) | Walnut oil fat emulsion and manufacturing method thereof | |
CN101253990A (en) | Soft capsules improving memory function | |
CN102106411B (en) | Nutrient oil for diabetics | |
CN102232430A (en) | Health-care oil | |
CN116570028A (en) | A composition containing nidus Collocaliae acid, phospholipid and polyunsaturated fatty acid, and its preparation method | |
CN114680336A (en) | Drop containing fructus cannabis unsaturated fatty acid and preparation method thereof | |
CN109527579A (en) | A kind of application of surprise Asia seed oil product and preparation method thereof and the sub- seed oil product of the surprise | |
CN108366600A (en) | For the method for the lotion with ω -3 to be prepared and stablized by the equiaxed crystal network of cellulose derivative | |
Jafari et al. | Plant oils rich in essential fatty acids | |
CN1141934C (en) | Health-care oil for regulating blood fat | |
CN114246331B (en) | Full-nutrition formula food suitable for special medical purpose of chronic obstructive pulmonary disease patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220701 |